Innovation

03/08/2021

IDIBELL’s Innovation Unit receives the UNE 166002:2014 certification

03/12/2020

IDIBELL has held a meeting with the best Healthtech projects

06/11/2020

IDIBELL and its fight against Covid-19

29/10/2020

Funding to study new drugs against autoimmune diseases

31/08/2020

ADmit Therapeutics receives 3.3 million euros from the European Commission to bring its early diagnosis test for Alzheimer’s to the market

08/05/2020

ADmit Therapeutics obtains the support of the Alzheimer’s Drug Discovery Foundation (ADDF) to develop its early Alzheimer’s diagnostic test.

08/04/2020

The health department will finance 3 IDIBELL’s projects on COVID-19

23/03/2020

An alternative drug to antibiotics receives the boost from the CaixaImpulse Consolidate program

21/11/2019

ADmit Therapeutics receives strong boost from competitive aid

12/11/2019

Innovation for value analyzes the use of big data and the new power it gives to patients

Scroll to Top